Missing/wrong data?
Log in to edit
Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial
scientific article published on 19 September 2005
Author/s
author: Brian G Weinshenker, Douglas S Goodin
Work details
Publication date
September 19, 2005
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.